IronMag Research Chems


ANABOLIC STEROIDS: THE NEXT GENERATION Selective Androgen Receptor Modulators

Results 1 to 12 of 12
  1. #1
    Senior Member
    ADMINISTRATOR
    Prince's Avatar


    Join Date
    Nov 2000
    Gender
    Male
    Location
    Panama
    Posts
    63,556
    Rep Points
    2147483647

    Post ANABOLIC STEROIDS: THE NEXT GENERATION Selective Androgen Receptor Modulators

    ANABOLIC STEROIDS: THE NEXT GENERATION Selective Androgen Receptor Modulators
    by Dan Gwartney, MD

    PQ: Nearly all of the SARM drugs moving forward into clinical trials are non-steroidal, meaning they are not based upon testosterone, but instead are modified receptor.

    A parent picking up his child at an elementary school might look into the chaotic crowd of kids, moving with the randomness that defines Brownian motion at a noise forms of other chemicals that are known to interact with and stimulate the androgen level that would make O’Hare airport seem like a library, hoping to glimpse a distinctive T-shirt to identify his progeny. Not only is it near impossible to discern little Johnny from his best friend Jimmy; he may look a lot like Janey, the tomboy. Fortunately, puberty makes gender distinction much easier.

    Many of the changes that occur during puberty are due to the effects of sex hormones; in men, this refers mainly to testosterone. However, it has been argued that testosterone is in many ways a prohormone, as it is converted in the body (male and female) into estradiol (a potent estrogen or female sex hormone) or dihydrotestosterone (a more potent androgen called DHT) in certain tissues. During puberty, many teens experience tenderness under the nipple or even breast growth due to an excess of estrogen called gynecomastia.1 Later in life, many men experience hair loss or problems urinating due to an enlarged prostate caused by an excess in DHT.2 Of course, testosterone is also an active and powerful hormone in its own right, stimulating the development of muscle mass and strength. The effects seen from testosterone or its metabolites, estradiol or DHT, are dependent (for the most part) on the interaction of the steroid with its respective receptor (testosterone, estradiol and DHT are all steroids). Obviously, the effects of the estrogen (estradiol) are much different from the androgens (testosterone and DHT), even though their chemical structures are similar. This is because estradiol does not interact strongly with the androgen receptor and the androgens do not interact strongly with the estrogen receptors. Looking specifically at the androgens, the effects are often divided into two classes, androgenic versus anabolic. Androgenic effects include those relating to reproductive glands or features that are gender-specific, such as penile length, deepening of the voice or hair growth/loss patterns. Many women who have used anabolic steroids experienced androgenic side effects, such as sounding more like a man or clitoral enlargement (the clitoris contains erectile tissue, similar to the penis but is normally smaller than a pencil eraser).3 Anabolic effects include growth and increased density of skeletal muscle and bone, which is the primary purpose for the use of anabolic steroids by athletes. Since the earliest days of androgen research, scientists have sought to separate the anabolic properties from androgenic and vice versa. The quest to develop drugs that are purely anabolic has been as fruitless as the quests of King Arthur’s knights as they sought out the Holy Grail. However, many interesting drugs were developed over the course of time that provided a greater ratio of anabolic to androgenic effects. In fact, many of the anabolic steroids developed were found to be highly anabolic, with relatively little androgenic burden as measured in labs. Of course, as the examples of many female athletes have shown, in women and children, even the “cleanest” anabolic steroid can cause androgenic effects when used in high enough doses. An additional problem is that most anabolic steroids interfere with the natural production of testosterone (and sperm), because the body reacts as it would if testosterone production was too high; it turns off the “on signal” from the brain, which effectively shuts down the testicles.4 Given the lack of federal support for research into anabolic steroids, bias against the steroid drug class due to sports doping and adolescent abuse, lack of patent protection (and thus profitability) and desire for an androgen-free anabolic (this would increase the consumer base to include women, children and men with androgen-sensitive tumors), pharmaceutical companies have returned to that grail-like quest of the “pure” anabolic. Though the properties vary somewhat depending on the specific use intended for a drug (bone-building to treat osteoporosis in the elderly; muscle-building to treat people with cancer or other wasting diseases; increase red blood cell production in cases of anemia; suppress testicular function for male contraception; increase libido for men and women, etc.), nearly every example of such drugs looks to provide the anabolic benefits without virilizing women or increasing prostate growth in men.5-14 As the benefits and side-effects are all outcomes from activating the same androgen receptor, the drugs have to be proven to be selective (stimulate anabolic effects without promoting androgenic effects). Hence, the emergence of the drug class known as SARM. Selective androgen receptor modulators (SARM) are drugs that activate the androgen receptor normally occupied by testosterone or its more androgenic metabolite, DHT. [There are some SARM that inhibit androgen receptor function, called anti-androgens, but this article will focus on the anabolic SARM.] The clinical effects of a SARM must provide the anabolic effects without producing any androgenic side effects at the same dose. A number of such drugs have been developed, with nearly every major pharmaceutical company reporting work in the area. This is surprising, as none of the companies are putting research and development money behind uses for testosterone, nandrolone or any of the other known anabolic steroids that have been in use for decades. Many of the challenges to using testosterone have been addressed. Clinicians noted that oral anabolic steroids were toxic to the liver, injectable esters produced noticeable highs and lows and topical preparations had a high rate of skin reactions.15,16 However, the latest generation of topical testosterone gels are well-tolerated and a long-acting ester that need only be injected once every three months, testosterone undecanoate, has been used for years in many other countries with favorable reviews.17 Therapies that do not exceed the physiologic range are being used safely with no significant increase in any adverse effects. In fact, many favorable responses are being noted with testosterone therapy. An insightful editorial on SARM drugs offered one suggestion as to why SARM drugs are selective.18 While acknowledging the probability that SARM drugs reach some tissues in higher concentration compared to testosterone, some lower; activate the androgen receptor in different ways; interact with the genes targeted by androgen-androgen receptor complexes; or are metabolized differently— a noted researcher in the field believes much of the specificity of SARM drugs may be due to the fact that they do not react with the enzyme 5-alpha-reductase. 5-alpha-reductase is the enzyme that converts testosterone to the more androgenic hormone, DHT.2 In the tissues that demonstrate an anabolic effect (muscle and bone for example), 5-alpha-reductase activity is much lower than in tissues that have an androgenic response (prostate and skin). This opinion coincides well with the observation that the anabolic steroid nandrolone (19-nortestosterone, Deca Durabolin) promotes muscle gains without affecting or even reducing the size of the prostate.19 Nandrolone does react with 5-alpha-reductase, but rather than converting to a more androgenic metabolite, it is converted to a less androgenic steroid.20 Unfortunately, using nandrolone without the additional support of an androgenic anabolic steroid may lead to problems with erectile dysfunction or libido loss, as nandrolone can suppress natural testosterone production. Undaunted, SARM research advances. Nearly all of the SARM drugs moving forward into clinical trials are non-steroidal, meaning they are not based upon testosterone, but instead are modified forms of other chemicals that are known to interact with and stimulate the androgen receptor. Certainly, there are some steroidal SARM drugs being studied, but they represent a distinct minority.12 Again, this may relate to the fact that the explosion in steroid research of the 1950s and 1960s resulted in the loss of patentability of most of the suitable steroidal SARM drug candidates. Research has been reported on SARM drugs that support bone density, increase/maintain the libido (sex drive) in female rats, inhibit sperm and testosterone production and reduce body fat.5-11 And…of course there has been research into the effect of SARM drugs on muscle.12-14 Remember, most all research revolves around rodents or tissue growing in sterile dishes in the lab. However, the results of a phase II study in the use of one SARM were reported that looked at the lean mass and physical performance benefits in a group of elderly men and women.21 Ostarine, the SARM most advanced through the development phase, was provided to 120 elderly people (60 men averaging 66 years of age; 60 women averaging 63 years of age) who were healthy. The subjects were divided into four groups based upon the ostarine dose provided; 0.1mg, 0.3mg, 1mg or 3mg per day. Tests were performed prior to therapy and after three months. The researchers discovered that ostarine provided a dose-dependent increase in lean mass and stair-climbing power, without increasing PSA (in men), sebum production (oily skin) or suppressing LH concentration (the “on signal” for natural testosterone production from the brain that is shut down by anabolic steroids). The study concluded that ostarine increased lean mass and strength without evidencing any androgenic side effects. Further ostarine research into its use in treating the wasting related to cancer is scheduled. This finding seems rather exciting; after all, it offers the benefits of anabolic steroids without the side effects. However, it remains unclear as to what value ostarine, or other SARM drugs may hold in the potential field of anabolic therapy for early andropause or strength and physique enhancement. The subjects in this study were all elderly, meaning they likely all were experiencing the age-related decline in anabolic hormones (testosterone, DHEA, growth hormone, etc). Also, the degree of gain in lean mass was only 1.4kg after three months of therapy for the highest dose group. The increase in speed (+15 percent) and power (+25 percent) measured during the stair-climbing was impressive though, suggesting the gain in lean mass was mostly muscle. It would have been helpful if changes in body composition were described as well.21 Two findings from the study were interesting from the perspective of possible use for enhancement therapies. The first was that the effects were dose-dependent, meaning the higher the dose, the greater the effects (within the range studied). This relationship between drug concentration and effect was also noted for testosterone enanthate in studies performed by noted researcher Shalender Bhasin.22,23 As no adverse side effects were noted, it would have been valuable to expand the drug range further to establish an upper limit for safety and efficacy. Secondly, ostarine had no effect on LH levels, meaning it did not suppress natural testosterone production. If natural testosterone concentrations are unaffected (this was not reported, so that would be an assumption), then the ostarine would be supplementing the anabolic effect of a person’s natural testosterone levels, in essence giving them the equivalent of a 125-200mg/week testosterone ester head start. It is difficult to say at this time where ostarine could best be used, but it is highly improbable that it will be approved for use in healthy, young adults or even people entering the beginning phases of andropause/menopause given the bias against physique or performance enhancement. Yet, as a drug that may offer a safe method of increasing one’s anabolic drive and support the effects of a healthy lifestyle of diet and exercise, ostarine is intriguing. The pharmaceutical companies are already cautioning against the entry of SARM drugs into a doping athlete’s regimen, but one can understand the appeal to such a crowd. The reported properties of ostarine suggest it could be a safe oral anabolic that could be taken alone by men and women alike, or stacked with injectable anabolic steroids to allow a greater anabolic response with less androgenic exposure. It is also possible that ostarine could be used as a bridge during post-cycle therapy, as it does not appear to suppress LH production (or recovery in the case of anabolic steroid use). Of course, SARM drugs may turn out to be no more effective than anabolic steroids combined with partial 5-alpha-reductase blockade and they may lack some of the physiologic effects such as diversion of mesenchymal stem cells toward muscle cell development and away from fat cell development or the upregulation of androgen receptors.24,25 It is much too early to tell.

    The same ethical arguments against anabolic steroid use will surely be measured against SARM use, whether it is muscle-building by bodybuilders, strength gains by football players, fracture prevention by gymnasts or hematocrit (red blood cell) increases by cyclists and marathoners. Sadly, the ethics of sports doping will likely delay the essential research that is necessary to understand the potential value future SARM drugs may have for treating the aging-related decline in anabolic metabolism or quality-of-life enhancement for responsible adults. Hopefully, research into these fields will commence to increase the understanding of SARM drugs’ roles in assisting in the battle against the societal epidemic of obesity and promotion of fitness-based lifestyles.

    References:

    1. Lazala C, Saenger P. Pubertal gynecomastia. J Pediatr Endocrinol Metab, 2002;15:553-60.

    2. Gormley GJ. Finasteride: a clinical review. Biomed Pharmacother, 1995:49:319-24.

    3. Kibble MW, Ross MB. Adverse effects of anabolic steroids in athletes. Clin Pharm, 1987;6:686-92.

    4. Turek PJ, Williams RH, et al. The reversibility of anabolic steroid-induced azoospermia. J Urol, 1995;153:1628-30.

    5. Kilbourne EJ, Moore WJ, et al. Selective androgen receptor modulators for frailty and osteoporosis. Curr Opin Investig Drugs, 2007;8:821-9.

    6. Manfredi MC, Bi Y, et al. Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators. Bioorg Med Chem Lett, 2007;17:4487-90.

    7. Kearbey JD, Gao W, et al. Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res, 2007;24:328-35.

    8. Wu D, Wu Z, et al. Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic characteristics of a propanamide in preclinical study. Drug Metab Dispos, 2006;34:483-94.

    9. Bohl CE, Chang C, et al. A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor. J Med Chem, 2004;47:3765-76.

    10. Allan GF, Tannenbaum P, et al. A selective androgen receptor modulator with minimal prostate hypertrophic activity enhances lean body mass in male rats and stimulates sexual behavior in female rats. Endocrine, 2007;32:41-51.

    11. Chen J, Hwang J, et al. A selective androgen receptor modulator for hormonal male contraception. J Pharmacol Exp Ther, 2005;312:546-53.

    12. Page ST, Marck BT, et al. Tissue Selectivity of the Anabolic Steroid, 19-Nor-4-Androstenediol-3{beta},17{beta}-diol in Male Sprague Dawley Rats: Selective Stimulation of Muscle Mass and Bone Mineral Density Relative to Prostate Mass. Endocrinology, 2007 Dec 20. Epub ahead of print.

    13. Rosen J, Negro-Vilar A. Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile. J Musculoskelet Neuronal Interact, 2002;2:222-4.

    14. Hong MH, Sun H, et al. Cell-specific activation of the human skeletal {alpha}-actin by androgens. Endocrinology, 2007 Dec 6. Epub ahead of print.

    15. Pertusi R, Dickerman RD, et al. Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis? J Am Osteopath Assoc, 2001;101:391-4.

    16. Murphy M, Carmichael AJ. Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management. Am J Clin Dermatol, 2000;1:361-8.

    17. Yassin AA, Haffejee M. Testosterone depot injection in male hypogonadism: a critical appraisal. Clin Interv Aging, 2007;2:577-90.

    18. Gao W, Dalton J. Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase? Mol Interv, 2007;7:10-3.

    19. Karbalay-Doust S, Noorafshan A. Stereological study of the effects of nandrolone decanoate on the rat prostate. Micron, 2006;37:617-23.

    20. Sundaram K, Kumar N, et al. Different patterns of metabolism determine the relative anabolic activity of 19-norandrogens. J Steroid Biochem Mol Biol, 1995;53:253-7.

    21. Evans W, Smith MR, et al. Ostarine increases lean body mass and improves physical performance in healthy elderly subjects: implications for cancer cachexia patients. 2007 American Society of Clinical Oncology Meeting. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings Part I. 2007;25 Suppl:9119.

    22. Woodhouse LJ, Gupta N, et al. Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab, 2004;89:718-26.

    23. Bhasin S, Woodhouse L, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab, 2001;281:E1172-81.

    24. Sinha-Hikim I, Taylor WE, et al. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: upregulation by androgen treatment. 2004;89:5245-55.

    25. Bhasin S, Taylor WE, et al. The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol A Biol Sci Med Sci, 2003;58:M1102-10.


    source


    IronMagLabs 15% Discount Code: Robert15






    IronMag Research 15% Discount Code: Robert15



  2. #2
    Senior Member
    ELITE MEMBER


    Join Date
    Aug 2006
    Gender
    Male
    Location
    someplace else
    Posts
    1,530
    Rep Points
    20425517

    I've been reading a lot of good reviews on this stuff. Looks very promising. Anyone else considering a SARMs?

  3. #3
    Gatekepper
    ELITE MEMBER
    Pirate!'s Avatar


    Join Date
    Jun 2004
    Location
    Texas
    Posts
    6,579
    Rep Points
    16274791

    I believe S4 is the only one currently being used for muscle gains. It has it's risks.
    Disclaimer: All health, fitness, diet, nutrition, anabolic steroid & supplement information posted here is intended for educational and informational purposes only, and is not intended as a substitute for proper medical advice from a medical doctor. We do not condone the use of anabolic steroids (AAS), all information about AAS is for educational and entertainment purposes only. If you choose to use AAS it's your responsibility to know the laws of the country that you live in. Consult your physician or health care professional before performing any of the exercises, or following any diet, nutrition or supplement advice described on this website.

    How to Use HCG

  4. #4
    Senior Member
    ELITE MEMBER


    Join Date
    Aug 2006
    Gender
    Male
    Location
    someplace else
    Posts
    1,530
    Rep Points
    20425517

    Quote Originally Posted by Pirate! View Post
    It has it's risks.
    Are there any worse then PH's or AAS? From what I've read so far I haven't found much as far as sides.

  5. #5
    Registered User
    tballz's Avatar


    Join Date
    Sep 2009
    Location
    USA
    Posts
    468
    Rep Points
    13177068

    Sides are night vision problems and yellowish tint with lights but those go away about 5 days or so after last use.

    I've also read where people have softer stools.

  6. #6
    Registered User
    TrashMan's Avatar


    Join Date
    Dec 2009
    Location
    Purgatory
    Posts
    92
    Rep Points
    562225

    Softer stool would be nice...

  7. #7
    Senior Member
    ELITE MEMBER


    Join Date
    Aug 2006
    Gender
    Male
    Location
    someplace else
    Posts
    1,530
    Rep Points
    20425517

    I did read about the vision problems but thought that was pre S4 versions. I've also heard there were some unknowns regarding receptors "resetting", I think was the term used, after discontinuing use.
    It would seam the biggest concern would be with the lack of many sides this would be prone to abuse from those who would take exceptionally large dosages from those thinking if a little is good allot must be better.

  8. #8
    Registered User
    weldingman's Avatar


    Join Date
    Dec 2009
    Gender
    Male
    Location
    Myrtle Beach, SC
    Posts
    1,224
    Rep Points
    11888505

    we are all juice freaks
    merry xmas

  9. #9
    Senior Member
    ELITE MEMBER


    Join Date
    Aug 2006
    Gender
    Male
    Location
    someplace else
    Posts
    1,530
    Rep Points
    20425517

    After reading forum after forum I've found that the vision issues were very dosage dependent. If you stick with 50mg to 75mg you're OK. Guys with the severe problems were up to 300mg a day.
    More info I've found:
    SARMS Selective Androgen Receptor Modulators | Sport Bodybuilding And Steroid Use

  10. #10
    Registered User


    Join Date
    Jan 2008
    Location
    United States
    Posts
    233
    Rep Points
    6208663

    some very good sarms info here. All the sarms logs i have seen people seem to be getting noticeable strength gains and weight loss. I was thinking about running a sarms/clen combo.

  11. #11
    Senior Member
    ELITE MEMBER


    Join Date
    Aug 2006
    Gender
    Male
    Location
    someplace else
    Posts
    1,530
    Rep Points
    20425517

    I'm giving it two weeks @ 50 mg a day in a split dose by it self. If any worth while gains start happening I'll post'em up.
    The taste is horrible. Definitely needs to be mixed with something then needs a chaser.

  12. #12
    Sssssssssssssss


    Join Date
    Jan 2008
    Gender
    Male
    Location
    california
    Posts
    260
    Rep Points
    7597772

    Thanks rahaas, would love to hear about the results with a smaller dosage, hope you still see the same gains

Similar Threads

  1. Androgen Action and the Androgen Receptor
    By Prince in forum Articles
    Replies: 0
    Last Post: 06-27-2011, 01:52 PM
  2. Replies: 0
    Last Post: 03-10-2011, 01:07 PM
  3. Replies: 1
    Last Post: 03-27-2009, 08:08 PM
  4. Androgen Receptor Regulation
    By Pirate! in forum Anabolic Zone
    Replies: 5
    Last Post: 11-19-2005, 11:49 AM
  5. Androgen receptor degredation
    By Purdue Power in forum Supplements
    Replies: 24
    Last Post: 08-31-2004, 12:25 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
-->